SBI Securities’s Exagen XGN Stock Holding History

SBI Securities’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,050	Closed	-$20.7K	–	4212
2024 Q4	$20.7K	Buy	+5,050	New	+$18.2K	﹤0.01%	1336

Other funds holding XGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SBI Securities's XGN Position: Q1 2025 in Review

SBI Securities sold out of Exagen (XGN) in Q1 2025, closing a stake of 5,050 shares — an estimated $20.7K sold.

SBI Securities first reported a position in XGN in Q4 2024 and held it in 1 quarter. The position peaked at $20.7K in Q4 2024. 38 funds tracked by Wall St. Rank hold XGN as of Q1 2025.

SBI Securities reported no remaining Exagen position as of Q1 2025 after selling out during the quarter.
SBI Securities sold 5,050 Exagen shares in Q1 2025, an estimated $20.7K.
SBI Securities first reported a position in Exagen in Q4 2024 and held it in 1 quarter.
SBI Securities's Exagen position peaked at $20.7K in Q4 2024.
38 funds tracked by Wall St. Rank held Exagen as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.